The landscape of cancer treatment is constantly evolving, with a growing spotlight on identifying novel therapeutic targets for drug creation. Traditional therapies often attack rapidly dividing cells, leading to significant side consequences. However, the emergence of sophisticated genomic profiling techniques has revolutionized our knowledge of m